Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 2523 for cancer

Edit search filters
  1. Electronic Patient Reporting of Symptoms During Cancer Treatment

    La Crosse, WI, Eau Claire, WI, Mankato, MN

  2. A Study to Evaluate Neoadjuvant and Personalized Agents to Treat Breast Cancer

    Rochester, MN

  3. A Study to Compare Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors

    Rochester, MN

  4. A Study of SC-007 in Subjects With Advanced Cancer

    Rochester, MN

  5. A Study to Evaluate A Resilient Living Program for Patients with Advancer Cancer and Their Caregivers

    Rochester, MN

  6. Study of SBP-101 in Pancreatic Cancer

    Scottsdale/Phoenix, AZ

  7. A Study to Evaluate the Effectiveness and Safety of Fruquintinib (HMPL-013) in Patients With Metastatic Colorectal Cancer (FRESCO-2)

    Scottsdale/Phoenix, AZ, Rochester, MN, Jacksonville, FL

  8. Enhanced, EHR-facilitated Cancer Symptom Control (E2C2) Pragmatic Clinical Trial 

    Rochester, MN

  9. A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer

    Scottsdale/Phoenix, AZ

  10. A Study to Evaluate MEN1611 and Cetuximab in Mutated, Metastatic Colorectal Cancer Patients

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer